Wikipedia -WSS

Wikipedia

author：entertainment 2025-09-30 12:08:38 - browse：9

As a new class of diabetes and obesity medications has soared in popularity, so have the online outlets built to get them in the hands of patients. A new analysis of claims data from Trilliant Health suggests that collectively, telehealth companies — in particular, cash-pay options that market directly to consumers — could account for many of the patients with insurance claims for GLP-1 prescriptions in 2022.

Direct-to-consumer telehealth companies have offered an easier on-ramp for many patients to access prescriptions for a variety of conditions. And since the first GLP-1s were approved for obesity — promising up to 15% weight loss — many of those companies have capitalized on the approvals and surging demand to launch new weight loss businesses. Companies including Calibrate and Ro claim to have reached tens and hundreds of thousands of patients with their weight loss medication programs.

Collectively, their reach may be even larger. The Trilliant Health analysis, conducted on behalf of STAT, offers an early glimpse of the foothold those businesses have gained in GLP-1 prescribing. In a nationwide claims database of more than 300 million patients using both commercial and federal insurance, Trilliant Health found about 3.6 million people with a prescription claim for a GLP-1 — semaglutide, tirzepatide, or injectable liraglutide without insulin — in 2022. To determine where each patient may have gotten those prescriptions, they looked for a medical visit claim within three days of a prescription claim for a GLP-1 — the visit where the script was likely written. But they only found a matching visit for 53% of patients.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： At least 13 dead in Texas as scorching temps continue
Next article： Hospitals use virtual reality to design more inclusive rooms for kids

WSS

Change Healthcare cyberattack shows risk of industry consolidation

‘The Bear’ and hospitality in hospitals

Redefining sustainability for the pharmaceutical industry

Doctor of U.S. President Joe Biden says he is fit for duty

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

Change Healthcare cyberattack shows risk of industry consolidation

explore

Wikipedia

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

What does generative AI mean for health care? We asked experts

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Medical leaders decry Supreme Court decision on affirmative action

Readout Newsletter: GSK, Viking Therapeutics, mifepristone news

Medical records are filled with copy

Change Healthcare cyberattack shows risk of industry consolidation

Trump demands the U.S. pay no more for drugs than other countries … again

In venture capital firm's success, lessons for turning crisis into profit

hotspot

There should be a 'Moonshot' or 'Warp Speed' for rare diseases

Pfizer is about to make a big push in cancer. Will investors listen?

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

‘The Bear’ and hospitality in hospitals

Doctor of U.S. President Joe Biden says he is fit for duty

Doctor of U.S. President Joe Biden says he is fit for duty

Wikipedia

focus

Wikipedia

hotspot